ChadTangMD

Radiation Oncology • Houston, TX

Physician

Join to view full profile

Dr. Tang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tang's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Fax+1 713-563-6876

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2013 - 2017
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2013
Stanford University School of MedicineClass of 2012

Certifications & Licensure

FL State Medical License 2021 - Present
GA State Medical License 2023 - 2026
TX State Medical License 2017 - 2026
AZ State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
OK State Medical License 2020 - 2025
TN State Medical License 2023 - 2025
WA State Medical License 2023 - 2025
AL State Medical License 2023 - 2024
American Board of Radiology Radiation Oncology
Join now to see all

Clinical Trials

MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial Start of enrollment: 2020 Aug 19
Withdrawn
Phase 2
Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma Start of enrollment: 2018 Jun 14
Suspended
Phase 2
Roles: Contact, Principal Investigator
Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer Start of enrollment: 2019 Nov 20
Completed
Phase 2
Roles: Contact, Principal Investigator
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor Start of enrollment: 2018 Jul 31
Active, not recruiting
Phase 2
Roles: Principal Investigator, Contact
A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs) Start of enrollment: 2023 Oct 31
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials.
Alexander D Sherry, Timothy A Lin, Zachary R McCaw, Esther J Beck, Ramez Kouzy
International Journal of Cancer. 2024-12-01
Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation.
Marcus A Florez, Brian De, Roman Kowalchuk, Chad Tang, Andrew J Bishop
Radiotherapy and Oncology. 2024-12-01
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials.
Alexander D Sherry, Timothy A Lin, Zachary R McCaw, Esther J Beck, Ramez Kouzy
International Journal of Radiation Oncology, Biology, Physics. 2024-12-01

Press Mentions

KCA Brings Early-Career Clinicians Together for New Mentorship ProgramNovember 14th, 2024
Advances in Prostate Cancer Radiation OncologySeptember 20th, 2024
22 Research Highlights from the Past YearDecember 19th, 2022
Join now to see all